US Stocks
/
Intensity Therapeutics, Inc. Common stock Share Price
Intensity Therapeutics, Inc. Common stock Share Price

Intensity Therapeutics, Inc. Common stock Share Price

NASDAQ: INTS
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Intensity Therapeutics, Inc. Common stock Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Intensity Therapeutics, Inc. Common stock Share Price Chart

$0.00$0.00
L
Show Current Price
H

Intensity Therapeutics, Inc. Common stock Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-8.56
Revenue (TTM)
N/A
Return On Equity (TTM)
-97.73%
Profit Margin
N/A
Debt to Equity
0.18
Quarterly Earnings Growth YoY
23.97%

Intensity Therapeutics, Inc. Common stock Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$4.60M-$4.97M-$3.51M-$3.35M-$2.54M-$2.67M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-7.99%29.33%4.73%24.20%-5.28%

Intensity Therapeutics, Inc. Common stock Annual Profit & Loss

All figures in USD

Particulars202320242025
RevenueN/AN/AN/A
Net Profit-$10.54M-$16.27M-$11.61M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-54.37%28.66%

About Intensity Therapeutics, Inc. Common stock

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Intensity Therapeutics, Inc. Common stock Historical Returns

MonthOpenCloseChange %

INTS Share Price FAQs

What is Intensity Therapeutics, Inc. Common stock share price today?

chevron-up
Intensity Therapeutics, Inc. Common stock share price today is $0.00 as on September 18, 2026 at 4:41 pm IST.

What is the 52 week high and 52 week low of Intensity Therapeutics, Inc. Common stock stock?

chevron-up
52 week high/low data for Intensity Therapeutics, Inc. Common stock is currently unavailable.

What is INTS's net income for the last quarter?

chevron-up
INTS's net income for the last quarter is -0.00B USD.

Can I buy INTS shares in India?

chevron-up
Yes. You can buy INTS in India by opening an international trading account.